1. Home
  2. IMRX vs EEA Comparison

IMRX vs EEA Comparison

Compare IMRX & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • EEA
  • Stock Information
  • Founded
  • IMRX 2008
  • EEA 1986
  • Country
  • IMRX United States
  • EEA Germany
  • Employees
  • IMRX N/A
  • EEA N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • EEA Trusts Except Educational Religious and Charitable
  • Sector
  • IMRX Health Care
  • EEA Finance
  • Exchange
  • IMRX Nasdaq
  • EEA Nasdaq
  • Market Cap
  • IMRX 73.2M
  • EEA 60.8M
  • IPO Year
  • IMRX 2021
  • EEA N/A
  • Fundamental
  • Price
  • IMRX $1.78
  • EEA $8.60
  • Analyst Decision
  • IMRX Buy
  • EEA
  • Analyst Count
  • IMRX 7
  • EEA 0
  • Target Price
  • IMRX $12.80
  • EEA N/A
  • AVG Volume (30 Days)
  • IMRX 801.9K
  • EEA 9.2K
  • Earning Date
  • IMRX 11-13-2024
  • EEA 01-01-0001
  • Dividend Yield
  • IMRX N/A
  • EEA 1.92%
  • EPS Growth
  • IMRX N/A
  • EEA N/A
  • EPS
  • IMRX N/A
  • EEA N/A
  • Revenue
  • IMRX N/A
  • EEA N/A
  • Revenue This Year
  • IMRX N/A
  • EEA N/A
  • Revenue Next Year
  • IMRX N/A
  • EEA N/A
  • P/E Ratio
  • IMRX N/A
  • EEA N/A
  • Revenue Growth
  • IMRX N/A
  • EEA N/A
  • 52 Week Low
  • IMRX $1.00
  • EEA $7.45
  • 52 Week High
  • IMRX $8.07
  • EEA $9.26
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 37.40
  • EEA 42.05
  • Support Level
  • IMRX $1.52
  • EEA $8.57
  • Resistance Level
  • IMRX $1.93
  • EEA $8.69
  • Average True Range (ATR)
  • IMRX 0.19
  • EEA 0.12
  • MACD
  • IMRX -0.05
  • EEA 0.01
  • Stochastic Oscillator
  • IMRX 21.95
  • EEA 28.89

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

Share on Social Networks: